These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10974665)

  • 21. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
    Simbrey K; Winterhoff H; Butterweck V
    Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription.
    Takeshita A; Koibuchi N; Oka J; Taguchi M; Shishiba Y; Ozawa Y
    Eur J Endocrinol; 2001 Oct; 145(4):513-7. PubMed ID: 11581012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of St. John's wort on free radical production.
    Hunt EJ; Lester CE; Lester EA; Tackett RL
    Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.
    Mueller SC; Majcher-Peszynska J; Uehleke B; Klammt S; Mundkowski RG; Miekisch W; Sievers H; Bauer S; Frank B; Kundt G; Drewelow B
    Eur J Clin Pharmacol; 2006 Jan; 62(1):29-36. PubMed ID: 16341856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes.
    Nöldner M; Chatterjee S
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S108-10. PubMed ID: 11518056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
    Wurglics M; Schubert-Zsilavecz M
    Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.